Trial Profile
A study evaluating effect of biologics on dermatology life quality index in Australasian psoriasis population
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 20 Mar 2018
Price :
$35
*
At a glance
- Drugs Adalimumab (Primary) ; Infliximab (Primary) ; Secukinumab (Primary) ; Ustekinumab (Primary) ; Etanercept
- Indications Psoriasis
- Focus Therapeutic Use
- 20 Mar 2018 New trial record